Quick Links
An initiative by leading Biopharmaceutical companies in the world to establish Singapore as the country of choice for global biomedical sciences manufacturing.
News
- All
- BMAC updates
- Press Release
- All
- BMAC updates
- Press Release
Pfizer expands manufacturing footprint in Singapore with new state-of-the-art facility | Singapore EDB
Pfizer Inc. today announced the extension of the company’s highly automated Active Pharmaceutical Ingredient (API) manufacturing facility in Tuas Biomedical Park, Singapore. The official opening ...
GSK set to achieve 100% renewable electricity at all manufacturing sites in Singapore from 2025 | Singapore EDB
GSK has today announced it has signed a 10-year energy deal with Sembcorp, covering the electricity demand for all three of GSK’s global manufacturing sites ...
WuXi AppTec breaks ground on new site in Singapore to better support global customers | Singapore EDB
WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, ...
16-week paid leave a work-life win| The Straits Times
Every parent of a newborn knows the toll of sleepless nights, and Mr Lam Wain Sion is no exception. However, thanks to the 16 weeks ...
Purpose, growth and camaraderie make up biopharma company’s formula for employee satisfaction | The Straits Times
When he was a child, Mr Shaji Alias watched a family member struggle with asthma and saw the difference that one of GSK’s medicines made. ...
16-weeks paid leave a work-life win
Every parent of a newborn knows the toll of sleepless nights, and Mr Lam Wain Sion is no exception. However, thanks to the 16 weeks ...
WuXi Biologics breaks ground on CRDMO center in Singapore | Singapore EDB
WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has broken ground on its new ...
BioPIPS consortium in Singapore expands membership, seeks to enhance productivity and sustainability in biologics manufacturing | Singapore EDB
The Biologics Pharma Innovation Programme Singapore (BioPIPS) consortium has been expanded with the addition of global immunotherapy company, BioNTech. The company joins global pharmaceutical companies ...
Novartis expands its biopharmaceutical manufacturing site in Singapore | Singapore EDB
Novartis today announced it broke ground for the expansion of its biopharmaceutical manufacturing plant in Singapore. The US$256 million investment will facilitate Novartis in deploying ...